Page last updated: 2024-08-21

alpha-aminopyridine and Amnesia-Memory Loss

alpha-aminopyridine has been researched along with Amnesia-Memory Loss in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Arahata, Y; Bundo, M; Ikenuma, H; Ito, K; Iwata, K; Kato, T; Kimura, Y; Nakamura, A; Nihashi, T; Okamura, N; Sakurai, K; Sakurai, T; Suzuki, K; Takeda, A; Washimi, Y; Yamaoka, A; Yanai, K1
Cho, J; Furumoto, S; Ido, T; Jeong, HJ; Kang, H; Kang, JM; Lee, H; Lee, KM; Lee, SY; Lee, YB; Na, DL; Noh, Y; Okamura, N; Park, KH; Seo, S; Seong, JK; Shin, DH; Villemagne, VL; Woo, SH; Yanai, K; Yeon, BK1
Shrivastava, SK; Sinha, SK1
De Ridder, D; Salembier, L; Van de Heyning, PH1
Andreani, A; Leoni, A; Locatelli, A; Morigi, R; Pietra, C; Rambaldi, M; Villetti, G1

Trials

1 trial(s) available for alpha-aminopyridine and Amnesia-Memory Loss

ArticleYear
The use of flupirtine in treatment of tinnitus.
    Acta oto-laryngologica. Supplementum, 2006, Issue:556

    Topics: Adult; Aminopyridines; Amnesia; Analgesics; Attention; Cost of Illness; Female; Humans; Male; Prospective Studies; Receptors, N-Methyl-D-Aspartate; Surveys and Questionnaires; Tinnitus; Treatment Outcome

2006

Other Studies

4 other study(ies) available for alpha-aminopyridine and Amnesia-Memory Loss

ArticleYear
Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
    Journal of Alzheimer's disease : JAD, 2022, Volume: 85, Issue:1

    Topics: Aged; Alzheimer Disease; Aminopyridines; Amnesia; Aniline Compounds; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Severity of Illness Index; tau Proteins; Thiazoles

2022
Tau positron emission tomography using [
    Neurobiology of aging, 2017, Volume: 59

    Topics: Aged; Alzheimer Disease; Aminopyridines; Amnesia; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Severity of Illness Index; tau Proteins

2017
Synthesis, evaluation and molecular dynamics study of some new 4-aminopyridine semicarbazones as an antiamnesic and cognition enhancing agents.
    Bioorganic & medicinal chemistry, 2013, Sep-01, Volume: 21, Issue:17

    Topics: Acetylcholinesterase; Aminopyridines; Amnesia; Animals; Behavior, Animal; Binding Sites; Brain; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Kinetics; Molecular Docking Simulation; Rats; Semicarbazones

2013
4-Aminopyridine derivatives with antiamnesic activity.
    European journal of medicinal chemistry, 2000, Volume: 35, Issue:1

    Topics: 4-Aminopyridine; Alzheimer Disease; Aminopyridines; Amnesia; Animals; Avoidance Learning; Carbon Dioxide; Indoles; Male; Mice; Nootropic Agents; Piracetam

2000